DoW Amyotrophic Lateral Sclerosis Research Program, Clinical Outcomes and Biomarkers Award
The FY26 ALS Research Program funds projects that develop and validate clinical outcomes and biomarkers for amyotrophic lateral sclerosis (ALS) to strengthen future clinical trials. Supported work can include biomarker discovery across susceptibility, diagnosis, monitoring, prognosis, prediction of response, and safety, as well as improving clinician- or patient-reported outcome measures (incl…
Source
Award
Dates
Eligibility
Keywords
Supporting Links
Documents
Similar Opportunities
-
DoW Amyotrophic Lateral Sclerosis Research Program, Therapeutic Development Award
Dept. of the Army -- USAMRAA
-
DoW Arthritis Clinical Research Award
Dept. of the Army -- USAMRAA
-
Biomedical Research Projects
Motor Neurone Disease Association
-
DoW Rare Cancers Resource and Community Development Award
Defense Health Agency Contracting Activity - DHACA
-
Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)
Department of Health and Human Services
Find tens of thousands more opportunities — free
Scout accounts are free. Sign up to browse the full funding database, unlock the solicitation links and documents for this opportunity, and see how well each one fits your organization.
-
Tens of thousands of funding opportunities
Search and filter every grant and solicitation in Scout — all free, no credit card required.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Save opportunities & track deadlines
Keep the opportunities that fit in one place and stay ahead of every due date.
Already have an account? Sign In
Trusted by 500+ Happy Customers